GABA-enhancing drug · Grey Matter

A GABA-enhancing drug is an antiseizure drug that strengthens the brain's main inhibitory signal, either by making GABA receptors respond more or by leaving more GABA at the synapse, and it is the fastest way to stop a seizure that is already running.

GABA-enhancing drug. A GABA-enhancing drug is an antiseizure drug that strengthens the brain's main inhibitory signal, either by making GABA receptors respond more or by leaving more GABA at the synapse, and it is the fastest way to stop a seizure that is already running.

Three mechanisms cover most of the class. Benzodiazepines (diazepam, lorazepam, midazolam) bind a site on the GABA-A receptor between its alpha and gamma subunits and make the chloride channel open more often when GABA is present. Barbiturates (phenobarbital) bind elsewhere on the same receptor and make each opening last longer; at high doses they can open the channel without GABA, which is part of why they are more dangerous. Vigabatrin works upstream: it irreversibly blocks GABA transaminase, the enzyme that breaks GABA down, so GABA levels rise; tiagabine blocks GABA reuptake and has a similar effect.

Benzodiazepines are the emergency drug. They act within minutes and are the first treatment for status epilepticus and for clusters of seizures, given into a vein, a muscle, the nose or the cheek.

They lose force with time and use. Tolerance develops with daily use, and during a prolonged seizure GABA-A receptors leave the synapse, so the later a benzodiazepine is given the less it does.

Vigabatrin is used for infantile spasms and for focal seizures that resist other drugs, and it can cause permanent loss of the peripheral visual field, so vision is monitored.

Sedation is the shared cost. Boosting inhibition everywhere also slows thought and causes sleepiness, which limits how far these drugs can be pushed.

These drugs lean on the brake the brain already has.

They work only where GABA signalling exists and responds, which is why they are fast in a fresh seizure and weaker once inhibition itself has been worn down.

Questions: How do benzodiazepines, barbiturates and vigabatrin strengthen inhibition in different ways? Benzodiazepines bind the GABA-A receptor between its alpha and gamma subunits and make its chloride channel open more often when GABA is present, so they amplify inhibition only where GABA is released. Barbiturates bind other sites on the same receptor and make each opening last longer, and at high doses they open it without GABA, which makes them more powerful and more dangerous. Vigabatrin acts upstream of the receptor: it permanently blocks GABA transaminase, the enzyme that breaks GABA down, so more GABA is available to be released. Why are benzodiazepines the first treatment for status epilepticus, and why do they work less the later they are given? Benzodiazepines act within minutes by making GABA-A receptors open more often, strengthening the inhibition that a seizure has overwhelmed, which is why guidelines put them first. During a prolonged seizure, however, synaptic GABA-A receptors are pulled into the cell, so there are fewer targets for the drug to act on. In animal models this internalisation tracks the loss of benzodiazepine effect, which is the main explanation for why delay matters and why second-line drugs act on other mechanisms.